New Pharmacologic Strategies for Allergic Rhinitis

Opinion statementCurrent treatment guidelines for allergic rhinitis (AR) recommend a stepwise therapeutic approach that combines patient education with specific allergen avoidance, symptomatic pharmacotherapy, and allergen immunotherapy (AIT). The available pharmacological strategies provide suboptimal symptom relief in patients with moderate-to-severe disease who continue to experience symptoms while treated, even on multiple therapies. The development of new symptomatic drugs with improved pharmacokinetics and safety has recently opened new perspective in the field of AR treatment, overcoming current limitations and increasing compliance to therapy. However, the ultimate research goal is beyond symptomatic treatment, and is mainly directed at modifying the immune response to allergens. In this direction, promising advances are expected in the fields of AIT and biological drugs. Significant research efforts are also focused on new therapeutic targets involved in the Th2-driven pathway inflammation.
Source: Current Treatment Options in Allergy - Category: Allergy & Immunology Source Type: research